HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Céline Amara Selected Research

tusamitamab ravtansine

12/2020Preclinical Activity of SAR408701: A Novel Anti-CEACAM5-maytansinoid Antibody-drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors.
1/2017Translational Model-Based Strategy to Guide the Choice of Clinical Doses for Antibody-Drug Conjugates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Céline Amara Research Topics

Disease

6Neoplasms (Cancer)
05/2024 - 01/2013
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 01/2023
1Cytokine Release Syndrome
05/2024
1Leukemia
01/2021
1Carcinoma (Carcinomatosis)
12/2020
1Breast Neoplasms (Breast Cancer)
12/2020

Drug/Important Bio-Agent (IBA)

2tusamitamab ravtansineIBA
12/2020 - 01/2017
2Immunoconjugates (Immunoconjugate)IBA
12/2020 - 01/2013
1AntigensIBA
05/2024
1CytokinesIBA
05/2024
1Interleukin-3 Receptors (Interleukin 3 Receptor)IBA
01/2023
1Immunoglobulin Fc FragmentsIBA
01/2021
1Bispecific AntibodiesIBA
01/2021
1Carcinoembryonic AntigenIBA
12/2020
1Cell Adhesion MoleculesIBA
12/2020
1Glycoproteins (Glycoprotein)IBA
12/2020
1Histones (Histone)IBA
12/2020
1TubulinIBA
12/2020
1AmidesIBA
02/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
02/2014
1PyrimidinonesIBA
02/2014
1TensinsIBA
02/2014
1indolineIBA
02/2014
1ProdrugsIBA
01/2013
1Monoclonal AntibodiesIBA
01/2013

Therapy/Procedure

2Therapeutics
05/2024 - 12/2020